Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism



Rating:

Share or cite this content

Citations should be made in the following way:
M. Acosta Davila (Valencia, Spain), S. Calvache Castillo (Valencia, Spain), C. De Juana Izquierdo (Valencia, Spain), A. Herrejón Silvestre (Valencia, Spain), I. Furest Carrasco (Valencia, Spain). Identification of patients with intermediate-high-risk PE with poor evolution. 3580

Member's Comments

No comment yet.

Related content which might interest you: Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis. Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Identification of p-stage I NSCLC patients with high risk of recurrence and poor prognosis by tumor marker index (TMI) Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Predictors of mortality in a well-characterised group of patients with COPD Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Identification of clinical phenotypes using cluster analyses in COPD patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Identification of intermediate-risk patients with acute symptomatic pulmonary embolism Source: Eur Respir J 2014; 44: 694-703 Year: 2014 Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials Source: Eur Respir J, 51 (1) 1701775; 10.1183/13993003.01775-2017 Year: 2018 Cluster analysis identifying patients with COPD at high-risk of 2-year mortality: preliminary results. Source: International Congress 2017 – Assessing the functional status of patients with COPD Year: 2017 Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 279-281 Year: 2016 Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 281-282 Year: 2016 Combination of prognostic tools for identifying high-risk normotensive patients with acute symptomatic pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Predicting adverse events from pulmonary embolism (PE): does the wicki score identify patients suitable for early discharge? Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003 Identifying risk groups for any cause hospitalizations in COPD patients Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Identifying patients with severe asthma that will be benefit from biological therapy Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 ESC/ERS low-risk profile achievement accurately predicts mortality in scleroderma-associated PAH Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Preselection of patients at high risk for COPD by simple screening questions Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016 Year: 2017